GLS and nasopharyngeal carcinoma: We next sought to investigate whether GLS1 isoforms are also upregulated in EBV-associated epithelial cancer cells using EBV-positive nasopharyngeal cancer cell line C666-1 and EBV-negative nasal epithelial carcinoma cell line RPMI 2650.